Results 141 to 150 of about 46,300 (164)

Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists.

JAMA Netw Open
Wang Z, Wang L, Zhang X, Lowery BD, Shaffer LL, Chen Y, Wells QS, Flynn CR, Williams B, Spann M, Srivastava G, Samuels JM, Yu D.   +12 more
europepmc   +1 more source

Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists.

JAMA Surg
Barrett TS, Hafermann JO, Richards S, LeJeune K, Eid GM.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly